Changes in Operation Profits in Korea's E-cigarette Market

Apr.12.2023
Changes in Operation Profits in Korea's E-cigarette Market
South Korean e-cigarette market sees changes in profits for major participants, with PMI rebounding and KT&G leading with 84% share.

On April 11th, according to a report by South Korean media outlet Bizwatch, there have been some new developments in the profit margins of major players in the country's electronic cigarette market. PhiMo International Korea saw a 163% increase in operating profit in 2022, while BAT Korea's operating profit decreased by 12%. KT&G has a profit margin of 30% and holds a market share of 84%, making it the top player in the South Korean market.


PMI's operating profit rebounds against market trends.


In 2022, there will be changes in the revenue of KT&G, PMI Korea, and BAT Korea.


KT&G and PMI Korea are the top two players in the South Korean electronic cigarette market, while BAT Korea is facing a growth standstill.


Analysts of the South Korean tobacco industry believe that the future profit lies in the electronic cigarette market as the tobacco industry shifts from traditional cigarettes to electronic ones.


According to industry insiders, in 2022, PMI's South Korean company's sales reached KRW 686.8 billion, representing a 21.5% increase compared to 2021. Operating profit increased by 162.5%, reaching KRW 80.6 billion. The operating profit margin increased from 5.4% in 2021 to 11.7% in 2022.


In 2022, KT&G's revenue was 36.94 trillion Korean won, representing a 5.8% increase from 2021. During this period, operating profit grew by 3.4% to reach 11.23 trillion Korean won, resulting in an operating profit margin of 30.3%.


KT&G's overseas tobacco exports and e-cigarette sales drove the growth, as demand for the domestic tobacco market decreased by 1% in 2022. KT&G's overseas cigarette sales in 2022 amounted to KRW 1.98 trillion, a 47.2% increase from 2021. Additionally, the sales of the company's next-generation product (NGP), with 2022 sales totaling KRW 87.63 billion, grew by 73.9%.


BAT Korea reported a 14.3% increase in revenue for 2022, reaching KRW 539.8 billion. However, the company's operating profit decreased by 12% to KRW 44.6 billion, resulting in a decline in operating profit margin from 10.7% in 2021 to 8.3% in 2022. Additionally, the net profit for 2022 decreased by 33.6%, reaching KRW 28.5 billion.


The market share of electronic cigarettes continues to grow.


Although cigarettes still dominate the South Korean tobacco market with a market share of approximately 85%, electronic cigarettes are rapidly replacing traditional cigarettes and are becoming the driving force behind the future profits of tobacco companies.


According to the "2022 Tobacco Market Trends" report released by the South Korean Ministry of Strategy and Finance, the market share of electronic cigarettes in the domestic tobacco market has been steadily increasing since 2017, rising from 2.2% to 9.6% in 2018, 10.5% in 2019, 10.6% in 2020, 12.4% in 2021, and 14.8% in 2022. After a period of stagnation in 2019 and 2020, the market share has been on the rise since 2021.


Changes in Market Share of E-cigarettes | Image Source: 2FIRSTS


In 2022, KT&G held a market share of 47.5% in convenience stores. Additionally, KT&G's electronic cigarette equipment made up 84% of the market share in the same year.


PMI's South Korean company has been actively targeting the electronic cigarette market, launching a new lineup called "IQOS Illuma One" in February 2023 after introducing iCos Illuma in October 2022.


Although KT&G and PMI compete in the domestic market, they have formed an alliance overseas. In January 2023, KT&G signed a 15-year agreement to provide PMI with smoke-free products in the international market (excluding South Korea). In exchange for marketing, distribution, and sales rights of KT&G e-cigarettes overseas, PMI guarantees a minimum distribution of cigarette units to ensure KT&G's profitability.


On the other hand, as reported, BAT has a market share of approximately 10% in the South Korean e-cigarette market. The company recently launched 'Glo HyperX2' in Korea with the goal of rebounding, but there hasn't been a significant shift in market share yet.


According to a Korean industry insider, "After a period of stagnation, the domestic e-cigarette market has slowly grown since 2022, and the challenge is how to further develop the market.


Related reading:


PMI's South Korean outsourcing factory has invested KRW 300 billion for the production of HNB devices.


Demand for heated tobacco in South Korea is expected to surge by 21% in 2022, while cigarette demand is set to decline by 1.8%.


References:


Last year's cigarette sales report shows that BAT Korea failed to meet its targets.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25